| 000 | 01793 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513223255.0 | ||
| 264 | 0 | _c20010215 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0929-1903 | ||
| 024 | 7 |
_a10.1038/sj.cgt.7700232 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSacco, M G | |
| 245 | 0 | 0 |
_aLymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. _h[electronic resource] |
| 260 |
_bCancer gene therapy _cOct 2000 |
||
| 300 |
_a1299-306 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 |
_aCD40 Antigens _xgenetics |
| 650 | 0 | 4 |
_aCD40 Ligand _xgenetics |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypergammaglobulinemia _ximmunology |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aImmunoglobulin M |
| 650 | 0 | 4 |
_aLymph Nodes _xultrastructure |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xetiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aUngari, M | |
| 700 | 1 | _aCatò, E M | |
| 700 | 1 | _aVilla, A | |
| 700 | 1 | _aStrina, D | |
| 700 | 1 | _aNotarangelo, L D | |
| 700 | 1 | _aJonkers, J | |
| 700 | 1 | _aZecca, L | |
| 700 | 1 | _aFacchetti, F | |
| 700 | 1 | _aVezzoni, P | |
| 773 | 0 |
_tCancer gene therapy _gvol. 7 _gno. 10 _gp. 1299-306 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cgt.7700232 _zAvailable from publisher's website |
| 999 |
_c11002222 _d11002222 |
||